Based on ratings from 0 stock analysts, the Lifevantage Corp stock price is expected to decrease by 100% in 12 months. This is calculated by using the average 12-month stock price forecast for Lifevantage Corp. The lowest target is $ and the highest is $. Please note analyst price targets are not guaranteed and could be missed completely.
LFVN is a stock in Consumer Defensive which has been forecasted to be worth $ as an average. On the higher end, the forecast price is $ USD by from and on the lower end LFVN is forecasted to be $ by from .
These are the latest 20 analyst ratings of LFVN.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Imperial Capital | In-Line | $2.1 | Initiates | Feb 12, 2014 |
When did it IPO
2004
Staff Count
222
Country
United States
Sector/Industry
Consumer Defensive/Packaged Foods
CEO
Mr. Steven R. Fife CPA
Market Cap
$183.0M
In 2023, LFVN generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that LFVN's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - LifeVantage Corporation (NASDAQ: LFVN) will hold its Q1 2025 Earnings Conference Call on October 29, 2024, at 4:30 PM ET, featuring CEO Steve Fife and CFO Carl Aure.
Why It Matters - LifeVantage's upcoming earnings call may reveal key financial performance metrics and strategic insights, influencing investor sentiment and stock valuation.
Summary - LifeVantage Corporation (Nasdaq: LFVN) announced its financial results for Q1 of fiscal 2024, ending September 30. Further details on performance were not provided in the excerpt.
Why It Matters - LifeVantage's financial results can impact stock performance and investor sentiment, influencing market perceptions of the company's growth potential and overall health in the wellness sector.
Summary - LifeVantage Corporation (Nasdaq: LFVN) will pay a quarterly cash dividend of $0.04 per share on December 16, 2024, to stockholders of record as of December 2, 2024.
Why It Matters - LifeVantage's quarterly cash dividend signals financial stability and commitment to returning value to shareholders, likely boosting investor confidence and potentially increasing stock demand.
Summary - LifeVantage Corporation (Nasdaq:LFVN) will release Q1 financial results for the period ending September 30, 2024, on October 29, 2024, after market close, followed by a conference call at 4:30 PM ET.
Why It Matters - LifeVantage's upcoming financial results release and conference call may impact stock performance, providing insights into company health and growth potential for investors.
Summary - A new dual-product system has demonstrated a 140% average increase in GLP-1, aiding in hunger hormone balance, reducing cravings, and promoting weight and visceral fat loss while preserving muscle.
Why It Matters - High demand for the dual-product system indicates strong market potential, which could lead to increased revenues and stock value for companies involved in weight management and health solutions.
Summary - Recent enhancements have been implemented to streamline processes for independent consultants, potentially improving their operational efficiency and success rates.
Why It Matters - Simplified pathways for independent consultants can boost their productivity and profitability, potentially increasing demand for related products and services, positively impacting market performance.